IsoPlexis Blog Application Note: Revolutionizing Adoptive Cell Therapy Development with Bruker's Beacon Platform

Adoptive cell therapy (ACT), the autologous or allogenic transplant of immune cells, is providing new hope in the ongoing battle against cancer. However, the path to harnessing the full potential of these therapies remains challenging, from understanding the intricate dynamics of individual cells to optimizing their therapeutic efficacy. Bruker's Beacon® Platform emerges as a transformative ...Application Note: Revolutionizing Adoptive Cell Therapy Development with Bruker's Beacon® Platform Read More »The post Application Note: Revolutionizing Adoptive Cell Therapy Development with Bruker's Beacon® Platform appeared first on Bruker Cellular Analysis.